Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 13, 2022
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
[ Fri, May 13th 2022
] - WOPRAI
Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $19 on, May 13th, 2022
Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $20 to $19 on, May 13th, 2022.
Jonathan has made no other calls on VINC in the last 4 months.
There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jonathan
- Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022
